ACTRN12613000101785已完成4 期
Pharmacokinetics of Subcutaneous Injection of Testosterone in an Oil Vehicle: A Randomised crossover study of Reandron (Testosterone Undecanoate) given subcutaneously and intramuscularly in hypogonadal men.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 11
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Male
入选标准
- •*Already receiving regular testosterone treatment.
- •*Written, informed consent & willing to comply with study requirements
排除标准
- •*Contraindication to testosterone
- •*History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements
- •*Regular medications that interfere with absorption, metabolism or action of testosterone which may require dosage change during the study
- •*Taking medications for antiplatelet or anticoagulant therapy
研究者
相似试验
已完成
3 期
Pharmacokinetics of Subcutaneous Injection (SC)of Testosterone in an Oil Vehicle: Nandrolone (ND) in Healthy VolunteersACTRN12613000068763Sydney Local Health District8
进行中（未招募）
不适用
Pharmacokinetics and Pharmacodynamics of subcutaneous applied insulin aspart administered with the FlexPen® insulin pen compared to inhaled insulinadministered with the Exubera® deviceEUCTR2007-002060-10-DEikfe GmbH
进行中（未招募）
不适用
A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children with Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin’s LymphomaT-cell or B-cell precursor (BCP) acute lymphoblastic leukaemia (T-ALL or BCP-ALL) or T-cell Non Hodgkin’s lymphoma (T-NHL)MedDRA version: 9.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaMedDRA version: 9.1Level: HLGTClassification code 10025321Term: Lymphomas non-Hodgkin's T-cellEUCTR2008-002219-42-CZMundipharma Research Limited28
进行中（未招募）
不适用
A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children with Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin’s LymphomaEUCTR2008-002219-42-ATMundipharma Research Limited28
进行中（未招募）
不适用
A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children with Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin’s LymphomaT-cell or B-cell precursor (BCP) acute lymphoblastic leukaemia (T-ALL or BCP-ALL) or T-cell Non Hodgkin’s lymphoma (T-NHL)MedDRA version: 9.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaMedDRA version: 9.1Level: HLGTClassification code 10025321Term: Lymphomas non-Hodgkin's T-cellEUCTR2008-002219-42-NLMundipharma Research Limited28